These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 700894)

  • 1. Secretion of plasminogen activator by normal, reactive and neoplastic human tissues cultured in vitro.
    Wilson EL; Dowdle E
    Int J Cancer; 1978 Oct; 22(4):390-9. PubMed ID: 700894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sensitive and specific assay for plasminogen activators.
    Smith DS; Harmon J; Owen WG
    Thromb Res; 1985 Feb; 37(4):533-41. PubMed ID: 4039078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro plasminogen activator activity in human brain tumors.
    Tucker WS; Kirsch WM; Martinez-Hernandez A; Fink LM
    Cancer Res; 1978 Feb; 38(2):297-302. PubMed ID: 620402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator content and secretion in explants of neoplastic and benign human prostate tissues.
    Camiolo SM; Markus G; Englander LS; Siuta MR; Hobika GH; Kohga S
    Cancer Res; 1984 Jan; 44(1):311-8. PubMed ID: 6197164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordinate expression of urinary-type plasminogen activator and its receptor accompanies malignant transformation of the ovarian surface epithelium.
    Young TN; Rodriguez GC; Moser TL; Bast RC; Pizzo SV; Stack MS
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 1):1285-96. PubMed ID: 8178854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies on the fibrinolytic, thrombolytic and fibrinogenolytic properties of a tissue plasminogen activator from guinea pig keratocytes.
    Electricwala A; Ling RJ; Sutton PM; Griffiths B; Riley PA; Atkinson T
    Thromb Haemost; 1985 Apr; 53(2):200-3. PubMed ID: 4040659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited fibrinolytic disorder due to an enhanced plasminogen activator level.
    Aznar J; Estellés A; Vila V; Regañón E; España F; Villa P
    Thromb Haemost; 1984 Oct; 52(2):196-200. PubMed ID: 6543037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDP D-dimer induces the secretion of interleukin-1, urokinase-type plasminogen activator, and plasminogen activator inhibitor-2 in a human promonocytic leukemia cell line.
    Hamaguchi M; Morishita Y; Takahashi I; Ogura M; Takamatsu J; Saito H
    Blood; 1991 Jan; 77(1):94-100. PubMed ID: 1845845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activators in human malignant melanoma.
    Markus G; Kohga S; Camiolo SM; Madeja JM; Ambrus JL; Karakousis C
    J Natl Cancer Inst; 1984 Jun; 72(6):1213-22. PubMed ID: 6374238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator content of neoplastic and benign human prostate tissues; fibrin augmentation of an activator activity.
    Camiolo SM; Markus G; Evers JL; Hobika GH; DePasquale JL; Beckley S; Grimaldi JP
    Int J Cancer; 1981 Feb; 27(2):191-8. PubMed ID: 6169657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator in normal and tumor-bearing mice.
    Bruesch MR; Johnson GL; Palackdharry CS; Weber MJ; Carl PL
    Int J Cancer; 1983 Jul; 32(1):121-6. PubMed ID: 6683248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach.
    Sier CF; Verspaget HW; Griffioen G; Ganesh S; Vloedgraven HJ; Lamers CB
    Gut; 1993 Jan; 34(1):80-5. PubMed ID: 8432457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fibrinolytic enzyme system in anorexia nervosa.
    Ogston D; Ogston WD
    Acta Haematol; 1976; 55(4):230-3. PubMed ID: 816162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction.
    Van de Werf F; Ludbrook PA; Bergmann SR; Tiefenbrunn AJ; Fox KA; de Geest H; Verstraete M; Collen D; Sobel BE
    N Engl J Med; 1984 Mar; 310(10):609-13. PubMed ID: 6537987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoradiometric quantification of tissue plasminogen activator secreted by fetal organs. Comparison with urokinase.
    Holmberg L; Kristoffersson AC; Lecander I; Wallén P; Astedt B
    Scand J Clin Lab Invest; 1982 Jun; 42(4):347-54. PubMed ID: 6753100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
    Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD
    Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.